The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

La Jolla Institute For Allergy And Immunology competitive analysis

Loading summary...

Latest patents of La Jolla Institute For Allergy And Immunology opposed by its competitors

Explore La Jolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2207597
Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1
EP2484696
Aug 16, 2017Antagonistic Hlight-Specific Human Monoclonal Antibodies1

Latest PTAB cases involving La Jolla Institute For Allergy And Immunology

Discover the latest PTAB cases involving La Jolla Institute For Allergy And Immunology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing La Jolla Institute For Allergy And Immunology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY - 2 - -
EUROPEAN OPPOSITIONS30 - - -